Alexander Plotnikov

Title: Alexander Plotnikov: Innovator in Receptor Protein Tyrosine Kinases

Introduction

Alexander Plotnikov is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of biochemistry, particularly in the study of receptor protein tyrosine kinases (RPTKs). His work focuses on the three-dimensional structures of these receptors and their ligands, which are crucial for understanding their functions and potential therapeutic applications.

Latest Patents

Alexander Plotnikov holds a patent for a "Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor." This patent describes the determination and use of three-dimensional structures of receptor protein tyrosine kinases and their ligands. The structures can facilitate the design and identification of modulators of RPTK function. These modulators have the potential to treat diseases that are mediated by inappropriate RPTK activity.

Career Highlights

Plotnikov is affiliated with New York University, where he continues to advance research in his field. His innovative work has garnered attention for its implications in medical science and drug development. He has a strong focus on the structural biology of RPTKs, which plays a vital role in cellular signaling and disease mechanisms.

Collaborations

Throughout his career, Alexander Plotnikov has collaborated with esteemed colleagues such as Joseph Schlessinger and Stevan R Hubbard. These collaborations have enriched his research and contributed to the advancement of knowledge in receptor biology.

Conclusion

Alexander Plotnikov is a prominent figure in the field of receptor protein tyrosine kinases, with a patent that highlights his innovative approach to understanding these critical proteins. His work has the potential to lead to significant advancements in the treatment of diseases linked to RPTK dysfunction.